Vaishali Pharma Limited has announced the closure of its trading window for dealing in the company's securities. This closure is effective from January 1, 2026, and is in preparation for the consideration of the unaudited financial results for the Fourth Quarter ended December 31, 2025. The trading window is scheduled to reopen 48 hours after the aforementioned financial results are made generally available to the public. Consequently, all company officers, designated employees, including directors and auditors, have been formally notified against trading in the company's equity shares during this restricted period.